Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sheep give Bioventix the advantage in immunodiagnostic market

This article was originally published in Clinica

Executive Summary

Rodents have long been used to provide monoclonal antibodies for the diagnostic testing market. However, UK firm Bioventix has pioneered the use of sheep cells to create more effective antibodies. Joseph Harvey met the firm’s CEO Peter Harrison to find out why sheep are the way forward for diagnostics

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094766

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel